Congratulations to Dieter Egli, PhD, the Maimonides Assistant Professor in the Division of Molecular Genetics, and the Berrie Center’s distinguished stem cell biologist, well on his way to creating viable, patient-specific, insulin-producing beta cells that will one day be delivered back to the patient for the treatment of type 1 diabetes (T1D).
He is the recipient of a host of recent honors and awards including a $600,000 grant from the American Diabetes Association and the Harold and Golden Lamport Research Award at Columbia University’s graduation. He also received a grant from the United States - Israel Binational Science Foundation to study human haploid embryonic Stem Cells with his colleague at the Hebrew University of Jerusalem, Dr. Nissim Benvenisty.
Human cells are considered diploid because they inherit two sets of chromosomes, 23 from the mother and 23 from the father. Reproductive egg and sperm cells are known as haploid because they contain a single set of chromosomes. They cannot divide to make more eggs and sperm. “What is fundamentally new is we have cells that can divide and renew with a single genome. That is just unprecedented,” said Dr. Egli.
Read about the breakthrough in creating embryonic stem cells.
Also read a story about Dolly the sheep in The Scientist magazine in which Dr. Egli is cited often.